European Institute of Oncology

Rising from the southern outskirts of Milan, the European Institute of Oncology, known internationally as the IEO, stands as a singular monument to the life and vision of its founder, Professor Umberto Veronesi. Unlike massive general hospitals that manage a broad spectrum of pathologies, the IEO is a hyper-specialized comprehensive cancer center where every square meter of the campus is dedicated exclusively to the eradication of oncological disease. The clinic is a member of EU-LIFE, an alliance of leading life science research centers in Europe, and cooperates with the University of Milan and IFOM Experimental Oncology Campus. As a result, cancer professionals see patients from all over the world: from the Middle East, Central and Eastern Europe, South America, and Saudi Arabia. It operates under a unique private non-profit status, a rare organizational model in the European healthcare landscape, which mandates that all financial surpluses are immediately reinvested into clinical and experimental research. This financial circularity creates an environment of perpetual modernization, where the transition from a laboratory hypothesis to a life-saving bedside treatment is executed with a speed and agility that few other institutions can match. The medical identity of the IEO is deeply rooted in the philosophy of minimal effective treatment, a concept pioneered by Veronesi himself when he revolutionized breast cancer care with the introduction of the quadrantectomy. This legacy of surgical restraint and biological precision continues to define the institute today, particularly within its world-leading breast program. As one of the highest-volume centers globally, the IEO has moved beyond simple tumor removal to the sophisticated preservation of the patient’s physical and psychological integrity. This is achieved through the integration of intraoperative radiotherapy (IORT) and the widespread use of sentinel lymph node biopsy, techniques that minimize surgical trauma while maximizing oncological outcomes. This commitment to reducing the invasiveness of cancer care is mirrored in the institute’s mastery of robotic surgery, where the da Vinci system is deployed across urological, gynecological, and gastrointestinal disciplines to perform microscopic dissections with superhuman accuracy. Technological dominance at the European Institute of Oncology has reached its current zenith with the inauguration of the IEO Proton Center, the most advanced form of high-precision radiotherapy available in modern medicine. Using proton beams that can be calibrated to deliver their maximum destructive energy precisely within the tumor mass while sparing surrounding healthy tissue, the clinic can treat complex or deep-seated cancers that were once considered inoperable or resistant to conventional radiation. This technological prowess is supported by a massive digital research engine focused on radiomics and artificial intelligence. Within the IEO’s experimental oncology departments, AI algorithms are trained on vast datasets of diagnostic images to detect the subtle, invisible signatures of malignancy long before they become apparent to the human eye, effectively shifting the battle against cancer from reactive treatment to proactive, ultra-early prevention. The facility is at the forefront of all critical advances in breast surgery and performs more than 3,600 surgeries annually. Over the years, doctors have developed original techniques and minimally invasive approaches, available only at the Institute of Oncology, thanks to the high professionalism of the staff, to improve the oncological and functional outcomes of interventions with minimal surgical impact. Head and neck surgeons perform more surgeries for malignant tumors annually than any other center.  Specialists were the first in Italy to offer conservative thyroid surgery, endoscopic non-surgical laryngeal surgery, and functional tongue surgery. Beyond the sterile precision of its laboratories and operating theaters, the IEO is defined by a deeply humanistic hospital without pain initiative and an architectural layout that prioritizes the patient’s quality of life. The institute is divided into specialized zones, such as the IEO 2 Day Center, which separates diagnostic workflows from therapeutic ones to reduce patient stress and clinical burden. The environment is designed to be one of clinical transparency, where multidisciplinary teams, comprising surgeons, medical oncologists, geneticists, and psychologists, converge around the patient rather than the patient navigating through various departments. This holistic integration ensures that the person is never lost within the complexity of their diagnosis.